Developmental and epileptic encephalopathy in patients with epilepsy due to hypothalamic hamartomas
Epilepsia · 2025
DOI: 10.1111/epi.18404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Kathrin Wagner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Epilepsy Center, Medical Center - University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Hamartoma, Hypothalamic Diseases, Epilepsy, Developmental Disabilities. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
What factors influence cognition and behavior in patients with epilepsy caused by hypothalamic hamartoma (HH)?
Methods
We conducted a retrospective study of 103 patients referred to the Epilepsy Center in Freiburg, Germany, over the past 24 years. Analyzed parameters included development/intellectual functioning, behavior, seizure types and frequency, as well as electroencephalography (EEG) and magnetic resonance imaging (MRI) analyses.
Results
Half of the patients showed signs of global developmental delay (GDD) or intellectual disability (ID). Patients with GDD/ID were younger at epilepsy onset ( p < .05) and at first referral ( p < .001), had shorter disease durations ( p < .01), experienced more frequent seizures ( p < .001), and were prescribed more antiseizure medication (ASM; p < .01). They also had larger HH volumes (hamartoma types Delalande III and IV, both p < .001) and more frequent pathological EEG background activity ( p < .001), as well as more extended interictal epileptiform discharges (IEDs; p < .05, the rate of IED and seizure types were comparable, p > .05). Of interest, pathological EEG background activity and HH type were the only predictors of GDD/ID resulting in a highly predictive model ( R 2 = 0.75, p < .001). Patients with GDD/ID also experienced more externalized behavioral problems, particularly aggression, which was predicted only by EEG background activity ( R 2 = 0.36, p < .001). None of the epilepsy‐specific parameters, such as duration and seizure type or frequency, were significant predictors. Significance Our findings support the idea that patients with epilepsy due to HH and GDD/ID may have a more severe underlying condition with a likely genetic etiology, characterized by developmental and epileptic encephalopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Epilepsy Center, Medical Center - University of Freiburg, Freiburg, Germany.
- Department of Neuroradiology, Medical Center - University of Freiburg, Freiburg, Germany.
- Department of Neuropediatric and Muscle Disorders, Medical Center - University of Freiburg, Freiburg, Germany.
ORCID-Profile: Kathrin Wagner, Theo Demerath, Sarah Metzger, Birgitta Metternich, Horst Urbach, Victoria San Antonio-Arce, Kerstin Alexandra Klotz, Andreas Schulze-Bonhage
Zitieren
APA
Wagner, K., Demerath, T., Metzger, S., Niedermoser, F., Metternich, B., Putzar, L., Urbach, H., San Antonio-Arce, V., Klotz, K. A., & Schulze-Bonhage, A. (2025). Developmental and epileptic encephalopathy in patients with epilepsy due to hypothalamic hamartomas. Epilepsia. https://doi.org/10.1111/epi.18404
Vancouver
Wagner K, Demerath T, Metzger S, Niedermoser F, Metternich B, Putzar L, et al. Developmental and epileptic encephalopathy in patients with epilepsy due to hypothalamic hamartomas. Epilepsia. 2025. doi:10.1111/epi.18404
BibTeX
@article{Wagner2025,
author = {Wagner, Kathrin and Demerath, Theo and Metzger, Sarah and Niedermoser, Friederike and Metternich, Birgitta and Putzar, Lisa and Urbach, Horst and San Antonio-Arce, Victoria and Klotz, Kerstin Alexandra and Schulze-Bonhage, Andreas},
title = {Developmental and epileptic encephalopathy in patients with epilepsy due to hypothalamic hamartomas},
journal = {Epilepsia},
year = {2025},
doi = {10.1111/epi.18404}
}
EUVIMED